Add Company
Join Now

Innoviva Specialty Therapeutics Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Innoviva Specialty Therapeutics's estimated annual revenue is currently $17.2M per year.(i)
  • Innoviva Specialty Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Innoviva Specialty Therapeutics has 111 Employees.(i)
  • Innoviva Specialty Therapeutics grew their employee count by 152% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Innoviva Specialty Therapeutics?

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease. Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.\n\nGrowing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients.

keywords:N/A

N/A

Total Funding

111

Number of Employees

$17.2M

Revenue (est)

152%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$38.7M11212%$511.5M
#2
$11.4M11415%N/A
#3
$11.4M1141%N/A
#4
$17.8M1155%$112.1M
#5
$29.4M117-28%N/A